Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T Post author: Post published:March 1, 2026 Post category: Continue ReadingLong-term Follow-up Study for Patients Treated With CLBR001 CAR-T
GDNF Gene Therapy for Parkinson’s Disease Post author: Post published:March 1, 2026 Post category: Continue ReadingGDNF Gene Therapy for Parkinson’s Disease
Claudin18.2 CAR-T (CT041) in Patients with Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers Post author: Post published:March 1, 2026 Post category: Continue ReadingClaudin18.2 CAR-T (CT041) in Patients with Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers
Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis. Post author: Post published:March 1, 2026 Post category: Continue ReadingSafety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.
Gene Transfer Study in Patients With Late Onset Pompe Disease Post author: Post published:March 1, 2026 Post category: Continue ReadingGene Transfer Study in Patients With Late Onset Pompe Disease
Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis Post author: Post published:March 1, 2026 Post category: Continue ReadingSafety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors Post author: Post published:March 1, 2026 Post category: Continue ReadingA Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors
CNS10-NPC for the Treatment of RP Post author: Post published:March 1, 2026 Post category: Continue ReadingCNS10-NPC for the Treatment of RP
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE) Post author: Post published:March 1, 2026 Post category: Continue ReadingA Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients Post author: Post published:March 1, 2026 Post category: Continue ReadingStudy of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients
